The Market Reports

Index

1 Pediatric Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs and Vaccines Revenue 2016-2027
1.4.2 Global Pediatric Drugs and Vaccines Sales 2016-2027
1.4.3 Pediatric Drugs and Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pediatric Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Drugs and Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue
2.5.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Drugs and Vaccines Sales by Country
3.3.2 North America Pediatric Drugs and Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Drugs and Vaccines Sales by Country
3.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Drugs and Vaccines Sales by Country
3.6.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Drugs and Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021)

5 Global Pediatric Drugs and Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck & Co., Inc. (USA)
6.1.1 Merck & Co., Inc. (USA) Corporation Information
6.1.2 Merck & Co., Inc. (USA) Description and Business Overview
6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.1.5 Merck & Co., Inc. (USA) Recent Developments/Updates
6.2 Abbott Laboratories (USA)
6.2.1 Abbott Laboratories (USA) Corporation Information
6.2.2 Abbott Laboratories (USA) Description and Business Overview
6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
6.2.5 Abbott Laboratories (USA) Recent Developments/Updates
6.3 Amgen, Inc. (USA)
6.3.1 Amgen, Inc. (USA) Corporation Information
6.3.2 Amgen, Inc. (USA) Description and Business Overview
6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.3.5 Amgen, Inc. (USA) Recent Developments/Updates
6.4 Eli Lilly and Company (USA)
6.4.1 Eli Lilly and Company (USA) Corporation Information
6.4.2 Eli Lilly and Company (USA) Description and Business Overview
6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly and Company (USA) Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
6.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
6.6 Genentech, Inc. (USA)
6.6.1 Genentech, Inc. (USA) Corporation Information
6.6.2 Genentech, Inc. (USA) Description and Business Overview
6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.6.5 Genentech, Inc. (USA) Recent Developments/Updates
6.7 GlaxoSmithKline plc. (UK)
6.6.1 GlaxoSmithKline plc. (UK) Corporation Information
6.6.2 GlaxoSmithKline plc. (UK) Description and Business Overview
6.6.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.7.5 GlaxoSmithKline plc. (UK) Recent Developments/Updates
6.8 Janssen Biologics B.V. (USA)
6.8.1 Janssen Biologics B.V. (USA) Corporation Information
6.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.8.5 Janssen Biologics B.V. (USA) Recent Developments/Updates
6.9 Actelion Pharmaceuticals
6.9.1 Actelion Pharmaceuticals Corporation Information
6.9.2 Actelion Pharmaceuticals Description and Business Overview
6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
6.9.5 Actelion Pharmaceuticals Recent Developments/Updates
6.10 AstraZeneca Plc. (UK)
6.10.1 AstraZeneca Plc. (UK) Corporation Information
6.10.2 AstraZeneca Plc. (UK) Description and Business Overview
6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.10.5 AstraZeneca Plc. (UK) Recent Developments/Updates
6.11 Boehringer Ingelheim GmbH (Germany)
6.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
6.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Description and Business Overview
6.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
6.12 Bristol-Myers Squibb Company (USA)
6.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
6.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.12.5 Bristol-Myers Squibb Company (USA) Recent Developments/Updates
6.13 Allergan, Inc. (USA)
6.13.1 Allergan, Inc. (USA) Corporation Information
6.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.13.5 Allergan, Inc. (USA) Recent Developments/Updates
6.14 Novartis AG (Switzerland)
6.14.1 Novartis AG (Switzerland) Corporation Information
6.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Description and Business Overview
6.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.14.5 Novartis AG (Switzerland) Recent Developments/Updates
6.15 Novo Nordisk A/S (Denmark)
6.15.1 Novo Nordisk A/S (Denmark) Corporation Information
6.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Description and Business Overview
6.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
6.15.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates
6.16 Pfizer, Inc. (USA)
6.16.1 Pfizer, Inc. (USA) Corporation Information
6.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.16.5 Pfizer, Inc. (USA) Recent Developments/Updates
6.17 Sanofi S.A (France)
6.17.1 Sanofi S.A (France) Corporation Information
6.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Description and Business Overview
6.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
6.17.5 Sanofi S.A (France) Recent Developments/Updates
6.18 Shionogi Inc. (USA)
6.18.1 Shionogi Inc. (USA) Corporation Information
6.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.18.5 Shionogi Inc. (USA) Recent Developments/Updates
6.19 Takeda
6.19.1 Takeda Corporation Information
6.19.2 Takeda Pediatric Drugs and Vaccines Description and Business Overview
6.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
6.19.5 Takeda Recent Developments/Updates

7 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
7.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
7.4 Pediatric Drugs and Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Drugs and Vaccines Distributors List
8.3 Pediatric Drugs and Vaccines Customers

9 Pediatric Drugs and Vaccines Market Dynamics
9.1 Pediatric Drugs and Vaccines Industry Trends
9.2 Pediatric Drugs and Vaccines Growth Drivers
9.3 Pediatric Drugs and Vaccines Market Challenges
9.4 Pediatric Drugs and Vaccines Market Restraints

10 Global Market Forecast
10.1 Pediatric Drugs and Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Type (2022-2027)
10.2 Pediatric Drugs and Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Application (2022-2027)
10.3 Pediatric Drugs and Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Pediatric Drugs and Vaccines Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pediatric Drugs and Vaccines Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pediatric Drugs and Vaccines Covered in This Study
Table 5. Global Pediatric Drugs and Vaccines Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pediatric Drugs and Vaccines Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Pediatric Drugs and Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pediatric Drugs and Vaccines Sales by Region (2016-2021) & (Kg)
Table 16. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 19. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 23. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Pediatric Drugs and Vaccines Sales (Kg) by Type (2016-2021)
Table 39. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Pediatric Drugs and Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pediatric Drugs and Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Pediatric Drugs and Vaccines Price (USD/Kg) by Type (2016-2021)
Table 43. Global Pediatric Drugs and Vaccines Sales (Kg) by Application (2016-2021)
Table 44. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Pediatric Drugs and Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pediatric Drugs and Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Pediatric Drugs and Vaccines Price (USD/Kg) by Application (2016-2021)
Table 48. Merck & Co., Inc. (USA) Corporation Information
Table 49. Merck & Co., Inc. (USA) Description and Business Overview
Table 50. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product
Table 52. Merck & Co., Inc. (USA) Recent Developments/Updates
Table 53. Abbott Laboratories (USA) Corporation Information
Table 54. Abbott Laboratories (USA) Description and Business Overview
Table 55. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product
Table 57. Abbott Laboratories (USA) Recent Developments/Updates
Table 58. Amgen, Inc. (USA) Corporation Information
Table 59. Amgen, Inc. (USA) Description and Business Overview
Table 60. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 62. Amgen, Inc. (USA) Recent Developments/Updates
Table 63. Eli Lilly and Company (USA) Corporation Information
Table 64. Eli Lilly and Company (USA) Description and Business Overview
Table 65. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product
Table 67. Eli Lilly and Company (USA) Recent Developments/Updates
Table 68. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 69. F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
Table 70. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product
Table 72. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
Table 73. Genentech, Inc. (USA) Corporation Information
Table 74. Genentech, Inc. (USA) Description and Business Overview
Table 75. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 77. Genentech, Inc. (USA) Recent Developments/Updates
Table 78. GlaxoSmithKline plc. (UK) Corporation Information
Table 79. GlaxoSmithKline plc. (UK) Description and Business Overview
Table 80. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product
Table 82. GlaxoSmithKline plc. (UK) Recent Developments/Updates
Table 83. Janssen Biologics B.V. (USA) Corporation Information
Table 84. Janssen Biologics B.V. (USA) Description and Business Overview
Table 85. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product
Table 87. Janssen Biologics B.V. (USA) Recent Developments/Updates
Table 88. Actelion Pharmaceuticals Corporation Information
Table 89. Actelion Pharmaceuticals Description and Business Overview
Table 90. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product
Table 92. Actelion Pharmaceuticals Recent Developments/Updates
Table 93. AstraZeneca Plc. (UK) Corporation Information
Table 94. AstraZeneca Plc. (UK) Description and Business Overview
Table 95. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product
Table 97. AstraZeneca Plc. (UK) Recent Developments/Updates
Table 98. Boehringer Ingelheim GmbH (Germany) Corporation Information
Table 99. Boehringer Ingelheim GmbH (Germany) Description and Business Overview
Table 100. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product
Table 102. Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
Table 103. Bristol-Myers Squibb Company (USA) Corporation Information
Table 104. Bristol-Myers Squibb Company (USA) Description and Business Overview
Table 105. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product
Table 107. Bristol-Myers Squibb Company (USA) Recent Developments/Updates
Table 108. Allergan, Inc. (USA) Corporation Information
Table 109. Allergan, Inc. (USA) Description and Business Overview
Table 110. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 112. Allergan, Inc. (USA) Recent Developments/Updates
Table 113. Novartis AG (Switzerland) Corporation Information
Table 114. Novartis AG (Switzerland) Description and Business Overview
Table 115. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product
Table 117. Novartis AG (Switzerland) Recent Developments/Updates
Table 118. Novo Nordisk A/S (Denmark) Corporation Information
Table 119. Novo Nordisk A/S (Denmark) Description and Business Overview
Table 120. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product
Table 122. Novo Nordisk A/S (Denmark) Recent Developments/Updates
Table 123. Pfizer, Inc. (USA) Corporation Information
Table 124. Pfizer, Inc. (USA) Description and Business Overview
Table 125. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 127. Pfizer, Inc. (USA) Recent Developments/Updates
Table 128. Sanofi S.A (France) Corporation Information
Table 129. Sanofi S.A (France) Description and Business Overview
Table 130. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. Sanofi S.A (France) Pediatric Drugs and Vaccines Product
Table 132. Sanofi S.A (France) Recent Developments/Updates
Table 133. Shionogi Inc. (USA) Corporation Information
Table 134. Shionogi Inc. (USA) Description and Business Overview
Table 135. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product
Table 137. Shionogi Inc. (USA) Recent Developments/Updates
Table 138. Takeda Corporation Information
Table 139. Takeda Description and Business Overview
Table 140. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Takeda Pediatric Drugs and Vaccines Product
Table 142. Takeda Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Pediatric Drugs and Vaccines Distributors List
Table 146. Pediatric Drugs and Vaccines Customers List
Table 147. Pediatric Drugs and Vaccines Market Trends
Table 148. Pediatric Drugs and Vaccines Growth Drivers
Table 149. Pediatric Drugs and Vaccines Market Challenges
Table 150. Pediatric Drugs and Vaccines Market Restraints
Table 151. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027) & (Kg)
Table 152. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 153. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 154. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 155. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027) & (Kg)
Table 156. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 157. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 158. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 159. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2022-2027) & (Kg)
Table 160. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 161. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 162. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Drugs and Vaccines
Figure 2. Global Pediatric Drugs and Vaccines Market Share by Type in 2020 & 2027
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Mumps Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pediatric Drugs and Vaccines Market Share by Application in 2020 & 2027
Figure 11. Newborn
Figure 12. Infant
Figure 13. Child
Figure 14. Global Pediatric Drugs and Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pediatric Drugs and Vaccines Market Size 2016-2027 (US$ Million)
Figure 16. Global Pediatric Drugs and Vaccines Sales 2016-2027 (Kg)
Figure 17. Global Pediatric Drugs and Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2020
Figure 19. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Pediatric Drugs and Vaccines Players: Market Share by Revenue in 2020
Figure 21. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
Figure 23. Global Pediatric Drugs and Vaccines Sales Market Share by Region in 2020
Figure 24. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in 2020
Figure 26. U.S. Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Pediatric Drugs and Vaccines by Type (2016-2021)
Figure 51. Sales Market Share of Pediatric Drugs and Vaccines by Application (2016-2021)
Figure 52. Sales Market Share of Pediatric Drugs and Vaccines by Application in 2020
Figure 53. Revenue Share of Pediatric Drugs and Vaccines by Application (2016-2021)
Figure 54. Revenue Share of Pediatric Drugs and Vaccines by Application in 2020
Figure 55. Manufacturing Cost Structure of Pediatric Drugs and Vaccines
Figure 56. Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure 57. Pediatric Drugs and Vaccines Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed